3B Blackbio DX Ltd (3BBLACKBIO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 418147, "name": "3B Blackbio", "stock_name": "3B Blackbio", "full_name": "3B Blackbio DX Ltd", "name_url": "stocks-analysis/3b-blackbio", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,294.50", "chg": -7.15, "chgp": "-0.55%", "dir": -1, "prev_price": "1,301.65", "mcapval": "1,123.00 Cr", "mcap": "Micro Cap", "scripcode": 532067, "symbol": "3BBLACKBIO", "ind_name": "Healthcare Services", "ind_code": 18, "indexname": "India SENSEX", "isin": "INE994E01018", "curr_date": "May 08", "curr_time": "", "bse_nse_vol": "8.31 k", "exc_status": "Active", "traded_date": "May 08, 2026", "traded_date_str": "2026 05 08", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/3b-blackbio-418147-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "3B Blackbio DX Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/3b-blackbio-dx-ltd-is-rated-sell-3979450", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/3BBlackbioDXLtd_mojoScore_3979450.png", "date": "2026-05-07 10:11:23", "description": "3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "3B Blackbio DX Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-technical-momentum-shifts-amid-mixed-market-signals-3978768", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/3BBlackbioDXLtd_technicaldot_3978768.png", "date": "2026-05-07 08:02:06", "description": "3B Blackbio DX Ltd, a micro-cap player in the healthcare services sector, has recently exhibited a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a 2.88% gain on 7 May 2026, the stock’s technical indicators present a complex picture, reflecting both cautious optimism and lingering downside risks." }, { "title": "3B Blackbio DX Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/3b-blackbio-dx-ltd-is-rated-sell-3963079", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/3BBlackbioDXLtd_mojoScore_3963079.png", "date": "2026-04-26 10:10:24", "description": "3B Blackbio DX Ltd is rated Sell by MarketsMOJO. This rating was last updated on 23 March 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 26 April 2026, providing investors with the latest perspective on the company’s position." }, { "title": "3B Blackbio DX Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/3b-blackbio-dx-ltd-is-rated-sell-3947300", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/3BBlackbioDXLtd_mojoScore_3947300.png", "date": "2026-04-15 10:10:34", "description": "3B Blackbio DX Ltd is rated Sell by MarketsMOJO. This rating was last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 April 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "3B Blackbio DX Ltd Gains 2.41%: Technical Signals and Market Moves This Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-gains-241-technical-signals-and-market-moves-this-week-3943134", "imagepath": "", "date": "2026-04-11 17:09:19", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>6 Apr:</strong> Week opens at Rs.1,194.00</p>\n <p><strong>7 Apr:</strong> Death Cross formation signals potential bearish trend</p>\n <p><strong>8 Apr:</strong> Technical momentum deteriorates; stock rebounds +4.20%</p>\n <p><strong>9 Apr:</strong> Price dips amid mixed market sentiment</p>\n <p><strong>10 Apr:</strong> Week closes at Rs.1,222.75 (+2.41% weekly gain)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,194.00</div></div>\n <div class=\"stat-item\"><div ..." }, { "title": "3B Blackbio DX Ltd Faces Bearish Momentum Amid Technical Downturn", "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-faces-bearish-momentum-amid-technical-downturn-3936353", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/3BBlackbioDXLtd_technicaldot_3936353.png", "date": "2026-04-08 08:01:07", "description": "3B Blackbio DX Ltd, a micro-cap player in the healthcare services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This change is reflected across multiple technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling increased selling pressure and subdued investor sentiment as the stock price continues to struggle below key resistance levels." }, { "title": "3B Blackbio DX Ltd Forms Death Cross, Signalling Potential Bearish Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-forms-death-cross-signalling-potential-bearish-trend-3936125", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/3BBlackbioDXLtd_dealthcross_3936125.png", "date": "2026-04-07 18:00:24", "description": "3B Blackbio DX Ltd, a micro-cap player in the Healthcare Services sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential deterioration in the stock’s trend and raises concerns about sustained weakness in the near to medium term." }, { "title": "3B Blackbio DX Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/3b-blackbio-dx-ltd-is-rated-sell-3932899", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/3BBlackbioDXLtd_mojoScore_3932899.png", "date": "2026-04-04 10:10:35", "description": "3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "3B Blackbio DX Ltd Falls to 52-Week Low of Rs 1110 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-falls-to-52-week-low-amidst-market-downturn-3929875", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/3BBlackbioDXLtd_priceRelatedfactors_3929875.png", "date": "2026-04-02 09:37:39", "description": "" } ], "total": 298, "sid": "418147", "stock_news_url": "https://www.marketsmojo.com/news/3b-blackbio-dx-418147" }, "announcements": [ { "caption": "Securities Of The Companies Permitted To Trade And Admitted To Dealings On The National Stock Exchange", "datetime": "21-Apr-2026", "details": "Securities of the Companies permitted to trade and admitted to dealings on the National Stock Exchange", "source": "BSE" }, { "caption": "Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2", "datetime": "15-Apr-2026", "details": "<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>3B BlackBio Dx Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L24211MP1972PLC001131</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2021-2022</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>NA</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>NA</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Navneet kaur</td></tr><tr><td>Designation :-</td><td>Company Secretary</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Nikhil Kuber dubey</td></tr> <tr><td>Designation : -</td><td>CFO and Whole Time Director</td></tr></table><div> <br/> Date: 15/04/2026<br/><br/></div>", "source": "BSE" }, { "caption": "Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2", "datetime": "15-Apr-2026", "details": "<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>3B BlackBio Dx Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L24211MP1972PLC001131</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>NA</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>NA</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Navneet Kaur</td></tr><tr><td>Designation :-</td><td>Company Secretary</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Nikhil Kuber Dubey</td></tr> <tr><td>Designation : -</td><td>CFO and Whole Time Director</td></tr></table><div> <br/> Date: 15/04/2026<br/><br/></div>", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "3B Blackbio DX Ltd has declared <strong>40%</strong> dividend, ex-date: 19 Sep 25", "dt": "2025-09-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

6 Apr: Week opens at Rs.1,194.00

7 Apr: Death Cross formation signals potential bearish trend

8 Apr: Technical momentum deteriorates; stock rebounds +4.20%

9 Apr: Price dips amid mixed market sentiment

10 Apr: Week closes at Rs.1,222.75 (+2.41% weekly gain)

Week Open

Rs.1,194.00

Read full news article

3B Blackbio DX Ltd Faces Bearish Momentum Amid Technical Downturn

2026-04-08 08:01:07

3B Blackbio DX Ltd, a micro-cap player in the healthcare services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This change is reflected across multiple technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling increased selling pressure and subdued investor sentiment as the stock price continues to struggle below key resistance levels.

Read full news article

3B Blackbio DX Ltd Forms Death Cross, Signalling Potential Bearish Trend

2026-04-07 18:00:24

3B Blackbio DX Ltd, a micro-cap player in the Healthcare Services sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential deterioration in the stock’s trend and raises concerns about sustained weakness in the near to medium term.

Read full news article

3B Blackbio DX Ltd is Rated Sell

2026-04-04 10:10:35

3B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

3B Blackbio DX Ltd Falls to 52-Week Low of Rs 1110 as Sell-Off Deepens

2026-04-02 09:37:39

Read full news article

Sr. No.	Particulars	Details
1	Name of Company	3B BlackBio Dx Ltd
2	CIN NO.	L24211MP1972PLC001131
3	Report filed for FY	2021-2022
Details of the Current block (all figures in Rs crore):
4	2 - year block period (Specify financial years)*	NA
5	Incremental borrowing done in FY (T)(a)	0.00
6	Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)	0.00
7	Actual borrowing done through debt securities in FY (T)(c)	0.00
8	Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)	0
8	Quantum of (d) which has been met from (c)(e)*	0
9	Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*	0

Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
2 - year Block period (Specify financial years)	NA
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#	0.00

Name of the Company Secretary :-	Navneet kaur
Designation :-	Company Secretary
Name of the Chief Financial Officer :-	Nikhil Kuber dubey
Designation : -	CFO and Whole Time Director